BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 6.11.2007

New Animal Drugs; Ractopamine

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Elanco Animal Health. The supplemental NADA provides for an increased level of monensin in three-way combination Type C medicated feeds containing ractopamine, monensin, and tylosin for cattle fed in confinement for slaughter and a revision to bacterial pathogen nomenclature.

Source: Federal Register — Food and Drug AdministrationOpen original release →